Central extracorporeal life support in pheochromocytoma crisis

Carlo Banfi; Francis Juthier; Pierre-Vladimir Ennezat; Timothee de Saint Denis; Bruno Carnaille; Emmanuelle Leteurtre; Alain Prat; André Vincentelli

doi:10.1016/j.athoracsur.2011.09.018

Central extracorporeal life support in pheochromocytoma crisis

Ann Thorac Surg. 2012 Apr;93(4):1303-5. doi: 10.1016/j.athoracsur.2011.09.018.

Authors

Carlo Banfi¹, Francis Juthier, Pierre-Vladimir Ennezat, Timothee de Saint Denis, Bruno Carnaille, Emmanuelle Leteurtre, Alain Prat, André Vincentelli

Affiliation

¹ Department of Cardiovascular Surgery, Centre Hospitalier Régional et Universitaire de Lille, Lille, France.

PMID: 22450084
DOI: 10.1016/j.athoracsur.2011.09.018

Abstract

Pheochromocytoma is a catecholamine-secreting tumor associated with clinical presentations ranging from paroxysmal hypertension to intractable cardiogenic shock. We report the use of central extracorporeal life support (ECLS) in a young woman admitted to the intensive care unit with cardiogenic shock. Her medical history included neurofibromatosis type I and pheochromocytoma. ECLS was needed because of severe left ventricular failure and inotropic therapy unresponsiveness. ECLS permitted full recovery of left ventricular function. Right adrenelectomy was performed 4 months later. In this case, central ECLS was used to treat pheochromocytoma-induced cardiogenic shock complicated by pulmonary edema.

MeSH terms

Extracorporeal Membrane Oxygenation*
Female
Humans
Neurofibromatosis 1 / complications*
Pheochromocytoma / etiology
Pheochromocytoma / surgery*
Pulmonary Edema / etiology
Pulmonary Edema / surgery*
Shock, Cardiogenic / etiology
Shock, Cardiogenic / surgery*
Ventricular Dysfunction, Left / etiology
Ventricular Dysfunction, Left / surgery
Young Adult